TapewireFind a company

person · Reporting owner

Scalet J Chris

Disclosed activity across 2 companies

Tapewire entity
12912
SEC CIK
0001348912

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Merck & Co., Inc.MRK · Entity 2807Exe V-P Global Srvs & CIOMay 02, 2012May 04, 2012

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Merck & Co., Inc.

Report date May 02, 2012 · Filed May 04, 2012

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2015-05-02Direct5,090 Reported balance After 2012-05-02 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2012-05-02 · Grant · Acquired 5,090 · Balance 5,090

F3: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $39.29 · Expires 2022-05-01Direct73,126 Reported balance After 2012-05-02 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2012-05-02 · Grant · Acquired 73,126 · Balance 73,126

F4: The option vests in three equal annual installments beginning May 2, 2013.

Common StockSEC Table I · non-derivativeDirect79,829.149 Reported balance Holding disclosure · report date 2012-05-02 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 79,829.149

F1: Holdings include shares acquired in dividend reinvestment transactions.

Common Stock - 401(k) PlanSEC Table I · non-derivativeIndirectBy 401(k)3,212.2852 Reported balance Holding disclosure · report date 2012-05-02 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 3,212.2852

F2: Includes shares acquired and dividends earned through April 6, 2012 in the MSD Employee Savings and Security Plan, a 401(k) plan.

Filing footnotes · ownership attribution and instrument terms

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: Includes shares acquired and dividends earned through April 6, 2012 in the MSD Employee Savings and Security Plan, a 401(k) plan.

F3: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F4: The option vests in three equal annual installments beginning May 2, 2013.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

IntraLinks Holdings, Inc.

Report date January 19, 2017 · Filed January 19, 2017

Section 16 reporting ended · disclosed 2017-01-19. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2017-01-19 transaction · row 1
1 source row

Row 1 · 2017-01-19 · Other · Disposed 82,760 · Balance 0

F1: Disposed of pursuant to the closing, on January 19, 2017, of a cash tender offer by GL Merger Sub, Inc., a wholly owned subsidiary of Synchronoss Technologies, Inc.

Filing footnotes · ownership attribution and instrument terms

F1: Disposed of pursuant to the closing, on January 19, 2017, of a cash tender offer by GL Merger Sub, Inc., a wholly owned subsidiary of Synchronoss Technologies, Inc.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
January 19, 2017 Filed Jan 19, 2017 17:30 UTC IntraLinks Holdings, Inc. IL · Entity 179553 OtherCommon Stock 82,760 $13.00 $1,075,880.00
Disclosure

SEC source: 0001488075-17-000045 · wf-form4_148486499121293.xml · nonDerivative · entry 1

Scalet J Chris · CIK 0001348912 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: Disposed of pursuant to the closing, on January 19, 2017, of a cash tender offer by GL Merger Sub, Inc., a wholly owned subsidiary of Synchronoss Technologies, Inc.

Read SEC document
May 02, 2012 Filed May 4, 2012 13:40 UTC Merck & Co., Inc. MRK · Entity 2807 GrantStock Option (right to buy) · Derivative 73,126 $0.00 Strike: $39.29 $0.00
Disclosure

SEC source: 0001225208-12-011190 · doc4.xml · derivative · entry 4

Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,126

Underlying: Common Stock · 73,126 shares

Expires 2022-05-01

F4 · derivative.exercise_date: The option vests in three equal annual installments beginning May 2, 2013.

Read SEC document
May 02, 2012 Filed May 4, 2012 13:40 UTC Merck & Co., Inc. MRK · Entity 2807 GrantRestricted Stock Unit · Derivative 5,090 $0.00 $0.00
Disclosure

SEC source: 0001225208-12-011190 · doc4.xml · derivative · entry 3

Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,090

Underlying: Common Stock · 5,090 shares

Expires 2015-05-02

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

Read SEC document
April 24, 2012 Filed Apr 26, 2012 19:30 UTC Merck & Co., Inc. MRK · Entity 2807 Exercise / conversionRSU - Leader Shares · Derivative 15,000 $38.27 $574,050.00
Disclosure

SEC source: 0001225208-12-010298 · doc4.xml · derivative · entry 7

Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2012-04-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

Read SEC document
April 24, 2012 Filed Apr 26, 2012 19:30 UTC Merck & Co., Inc. MRK · Entity 2807 Exercise / conversionRestricted Stock Unit · Derivative 11,700 $38.27 $447,759.00
Disclosure

SEC source: 0001225208-12-010298 · doc4.xml · derivative · entry 6

Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,700 shares

Expires 2012-04-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

Read SEC document
April 24, 2012 Filed Apr 26, 2012 19:30 UTC Merck & Co., Inc. MRK · Entity 2807 Tax withholdingCommon Stock 6,896 $38.27 $263,909.92
Disclosure

SEC source: 0001225208-12-010298 · doc4.xml · nonDerivative · entry 4

Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,829.149

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
April 24, 2012 Filed Apr 26, 2012 19:30 UTC Merck & Co., Inc. MRK · Entity 2807 Tax withholdingCommon Stock 4,253 $38.27 $162,762.31
Disclosure

SEC source: 0001225208-12-010298 · doc4.xml · nonDerivative · entry 3

Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,725.149

Read SEC document
April 24, 2012 Filed Apr 26, 2012 19:30 UTC Merck & Co., Inc. MRK · Entity 2807 Exercise / conversionCommon Stock 11,700 $0.00 $0.00
Disclosure

SEC source: 0001225208-12-010298 · doc4.xml · nonDerivative · entry 2

Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,978.149

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 24, 2012 Filed Apr 26, 2012 19:30 UTC Merck & Co., Inc. MRK · Entity 2807 Exercise / conversionCommon Stock 15,000 $0.00 $0.00
Disclosure

SEC source: 0001225208-12-010298 · doc4.xml · nonDerivative · entry 1

Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,278.149

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 28, 2012 Filed Mar 1, 2012 20:37 UTC Merck & Co., Inc. MRK · Entity 2807 GrantCommon Stock 8,709 $38.38 $334,251.42
Disclosure

SEC source: 0001225208-12-006225 · doc4.xml · nonDerivative · entry 1

Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,832.965

F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 2/27/09. Performance shares were paid out at 117 percent of target awards.

F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 04, 2011 Filed May 6, 2011 14:43 UTC Merck & Co., Inc. MRK · Entity 2807 GrantStock Option (right to buy) · Derivative 74,627 $0.00 Strike: $36.56 $0.00
Disclosure

SEC source: 0001225208-11-013368 · doc4.xml · derivative · entry 4

Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,627

Underlying: Common Stock · 74,627 shares

Expires 2021-05-03

F4 · derivative.exercise_date: The option vests in three equal annual installments beginning May 4, 2012.

Read SEC document
May 04, 2011 Filed May 6, 2011 14:43 UTC Merck & Co., Inc. MRK · Entity 2807 GrantRestricted Stock Unit · Derivative 5,470 $0.00 $0.00
Disclosure

SEC source: 0001225208-11-013368 · doc4.xml · derivative · entry 3

Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,470

Underlying: Common Stock · 5,470 shares

Expires 2014-05-04

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:08 UTC Merck & Co., Inc. MRK · Entity 2807 Exercise / conversionRestricted Stock Unit · Derivative 9,750 $32.19 $313,852.50
Disclosure

SEC source: 0001225208-11-007805 · doc4.xml · derivative · entry 4

Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,750 shares

Expires 2011-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:08 UTC Merck & Co., Inc. MRK · Entity 2807 Tax withholdingCommon Stock 3,545 $32.19 $114,113.55
Disclosure

SEC source: 0001225208-11-007805 · doc4.xml · nonDerivative · entry 2

Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,590.592

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
February 28, 2011 Filed Mar 1, 2011 20:08 UTC Merck & Co., Inc. MRK · Entity 2807 Exercise / conversionCommon Stock 9,750 $0.00 $0.00
Disclosure

SEC source: 0001225208-11-007805 · doc4.xml · nonDerivative · entry 1

Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,135.592

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 22, 2011 Filed Feb 24, 2011 17:02 UTC Merck & Co., Inc. MRK · Entity 2807 GrantCommon Stock 7,511 $32.34 $242,905.74
Disclosure

SEC source: 0001225208-11-007025 · doc4.xml · nonDerivative · entry 1

Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,385.592

F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 2/29/08. Performance shares were paid out at 122 percent of target awards.

F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
May 07, 2010 Filed May 11, 2010 20:35 UTC Merck & Co., Inc. MRK · Entity 2807 GrantStock Option (right to buy) · Derivative 78,031 $0.00 Strike: $33.49 $0.00
Disclosure

SEC source: 0001225208-10-012620 · doc4.xml · derivative · entry 4

Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,031

Underlying: Common Stock · 78,031 shares

Expires 2020-05-06

F4 · derivative.exercise_date: The option vests in three equal annual installments beginning May 7, 2011.

Read SEC document
May 07, 2010 Filed May 11, 2010 20:35 UTC Merck & Co., Inc. MRK · Entity 2807 GrantRestricted Stock Unit · Derivative 13,437 $0.00 $0.00
Disclosure

SEC source: 0001225208-10-012620 · doc4.xml · derivative · entry 3

Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,437

Underlying: Common Stock · 13,437 shares

Expires 2013-05-07

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

Read SEC document
March 02, 2010 Filed Mar 4, 2010 19:58 UTC Merck & Co., Inc. MRK · Entity 2807 Exercise / conversionRestricted Stock Unit · Derivative 7,650 $37.27 Strike: $0.00 $285,115.50
Disclosure

SEC source: 0001225208-10-007076 · doc4.xml · derivative · entry 4

Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,650 shares

Expires 2010-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

Read SEC document
March 02, 2010 Filed Mar 4, 2010 19:58 UTC Merck & Co., Inc. MRK · Entity 2807 Tax withholdingCommon Stock 2,781 $37.27 $103,647.87
Disclosure

SEC source: 0001225208-10-007076 · doc4.xml · nonDerivative · entry 2

Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,703.8585

F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions.

Read SEC document
March 02, 2010 Filed Mar 4, 2010 19:58 UTC Merck & Co., Inc. MRK · Entity 2807 Exercise / conversionCommon Stock 7,650 $0.00 $0.00
Disclosure

SEC source: 0001225208-10-007076 · doc4.xml · nonDerivative · entry 1

Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,484.8585

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 08, 2010 Filed Jan 26, 2010 19:35 UTC Merck & Co., Inc. MRK · Entity 2807 GrantCommon Stock 5,667 $37.72 $213,759.24
Disclosure

SEC source: 0001225208-10-002269 · doc4.xml · nonDerivative · entry 1

Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,834.8585

F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/02/2007. Performance shares were paid out at 120 percent of target awards.

Read SEC document
November 03, 2009 Filed Nov 6, 2009 00:06 UTC Merck & Co., Inc. MRK · Entity 2807 GrantStock Option (right to buy) · Derivative 62,400 $0.00 Strike: $23.45 $0.00
Disclosure

SEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 14

Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 62,400 shares

Expires 2019-04-23

F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

Read SEC document
November 03, 2009 Filed Nov 6, 2009 00:06 UTC Merck & Co., Inc. MRK · Entity 2807 GrantStock Option (right to buy) · Derivative 52,000 $0.00 Strike: $44.30 $0.00
Disclosure

SEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 13

Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 52,000 shares

Expires 2018-02-28

F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

Read SEC document
November 03, 2009 Filed Nov 6, 2009 00:06 UTC Merck & Co., Inc. MRK · Entity 2807 GrantStock Option (right to buy) · Derivative 40,800 $0.00 Strike: $44.19 $0.00
Disclosure

SEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 12

Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 40,800 shares

Expires 2017-03-01

F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

Read SEC document
November 03, 2009 Filed Nov 6, 2009 00:06 UTC Merck & Co., Inc. MRK · Entity 2807 GrantStock Option (right to buy) · Derivative 36,000 $0.00 Strike: $35.09 $0.00
Disclosure

SEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 11

Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 36,000 shares

Expires 2016-03-02

F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

Read SEC document
November 03, 2009 Filed Nov 6, 2009 00:06 UTC Merck & Co., Inc. MRK · Entity 2807 GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $31.84 $0.00
Disclosure

SEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 10

Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2015-02-24

F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

Read SEC document
November 03, 2009 Filed Nov 6, 2009 00:06 UTC Merck & Co., Inc. MRK · Entity 2807 GrantStock Option (right to buy) · Derivative 21,750 $0.00 Strike: $48.24 $0.00
Disclosure

SEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 9

Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 21,750 shares

Expires 2014-02-26

F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

Read SEC document
November 03, 2009 Filed Nov 6, 2009 00:06 UTC Merck & Co., Inc. MRK · Entity 2807 GrantStock Option (right to buy) · Derivative 42,200 $0.00 Strike: $55.00 $0.00
Disclosure

SEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 8

Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 42,200 shares

Expires 2013-04-30

F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

Read SEC document
November 03, 2009 Filed Nov 6, 2009 00:06 UTC Merck & Co., Inc. MRK · Entity 2807 GrantStock Option (right to buy) · Derivative 31,650 $0.00 Strike: $52.28 $0.00
Disclosure

SEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 7

Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 31,650 shares

Expires 2013-03-24

F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger.

Read SEC document
November 03, 2009 Filed Nov 6, 2009 00:06 UTC Merck & Co., Inc. MRK · Entity 2807 GrantRSU - Leader Shares · Derivative 15,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 6

Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2012-04-24

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule.

F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule.

F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule.

Read SEC document
November 03, 2009 Filed Nov 6, 2009 00:06 UTC Merck & Co., Inc. MRK · Entity 2807 GrantRestricted Stock Unit · Derivative 11,700 $0.00 $0.00
Disclosure

SEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 5

Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,700 shares

Expires 2012-04-24

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule.

F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule.

F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule.

Read SEC document
November 03, 2009 Filed Nov 6, 2009 00:06 UTC Merck & Co., Inc. MRK · Entity 2807 GrantRestricted Stock Unit · Derivative 9,750 $0.00 $0.00
Disclosure

SEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 4

Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,750 shares

Expires 2011-02-28

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule.

F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule.

F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule.

Read SEC document
November 03, 2009 Filed Nov 6, 2009 00:06 UTC Merck & Co., Inc. MRK · Entity 2807 GrantRestricted Stock Unit · Derivative 7,650 $0.00 $0.00
Disclosure

SEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 3

Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,650 shares

Expires 2010-03-02

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule.

F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule.

F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule.

Read SEC document
November 03, 2009 Filed Nov 6, 2009 00:06 UTC Merck & Co., Inc. MRK · Entity 2807 OtherCommon Stock - 401(k) Plan 2,608.7358 $0.00 $0.00
Disclosure

SEC source: 0001209191-09-051305 · c92126_4x0.xml · nonDerivative · entry 2

Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO

10b5-1 filing: Not disclosed

Ownership: Indirect · By 401(k)

Disclosed balance after: 0

F2 · price: Received as part of the Transactions in exchange for an equivalent number of shares of MSD common stock held under the MSD 401(k) plan.

Read SEC document
November 03, 2009 Filed Nov 6, 2009 00:06 UTC Merck & Co., Inc. MRK · Entity 2807 GrantCommon Stock 26,167.8585 $0.00 $0.00
Disclosure

SEC source: 0001209191-09-051305 · c92126_4x0.xml · nonDerivative · entry 1

Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: Received in exchange for an equivalent number of shares of Merck Sharp & Dohme Corp. (formerly Merck & Co., Inc.) ("MSD") common stock in connection with the completion of transactions contemplated by the Agreement and Plan of Merger by and among, inter alia, MSD and Merck & Co., Inc. (formerly Schering-Plough Corporation) (the "Transactions").

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.